Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1/2 3Phase NA 2Phase 2/3 1Phase 1 1

Status

Completed 2Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 1Other 1Head & Neck 1Genitourinary 1

Conditions

Urothelial Cancer 1Squamous Cell Carcinoma of Head and Neck 1Posterior Fossa Ependymal Tumor 1Polycystic Ovary Syndrome 1Obesity 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Specimen Handling 176Magnetic Resonance Spectroscopy 138Biopsy 102pembrolizumab 81Carboplatin 79Cisplatin 71Nivolumab 65Cyclophosphamide 64Paclitaxel 54Radiotherapy 48Gemcitabine 43durvalumab 39Doxorubicin 35Bevacizumab 34Fluorouracil 33venetoclax 32Dexamethasone 31Rituximab 30atezolizumab 29Radiation 29Capecitabine 28Lenalidomide 27Etoposide 27Prednisone 26Oxaliplatin 26Injections 26Pemetrexed 25Docetaxel 25olaparib 23fludarabine 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Metformin × 30 days × Clear all
NCT02186847 2026-05-22

Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer

NRG Oncology

Phase 2 Completed
170 enrolled 19 charts
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung

NCT07604870 2026-05-22

Krill Oil and Metformin in Women With PCOS and Metabolically Unhealthy Obesity

Firat University

Phase 2 Completed
54 enrolled
Other

Obesity, Polycystic Ovary Syndrome

NCT02365597 2026-05-08

An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer

Janssen Research & Development, LLC

Phase 2 Active not recruiting
239 enrolled 32 charts 1 FDA
Genitourinary

Urothelial Cancer

NCT04414540 2026-05-08

Combining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer Patients

University of Cincinnati

Phase 2 Active not recruiting
21 enrolled 12 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT07226453 2026-05-07

PNOC041

University of California, San Francisco

Phase 2 Recruiting
30 enrolled

Posterior Fossa Ependymal Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡